Correspondent elizabeth cohen. Elizabeth, youve got big picture. Youve got Good Progress on a vaccine, no question. Youve got multiple paths here, and they seem to be seeing good data in these early trials. You know, the question is are they getting a thumb on the scale right to push this out before they have enough data, so whats happening . Reporter all right. So, jim, theres no question but huge progress has been made. I mean to go from, you know, having heard of this for the first time in january, that we need to get a vaccine to having trials started in july in the u. S. , thats amazing. I dont know that we have good data. That has not been announced yet. Thats kept very quiet. There may be no data. You can start these trials and not get anywhere, so when pfizer and bio entech say they will have sufficient data to apply for, you know, permission from the fda to market it next month, we have no idea if thats true or not. We have no idea what that is based on, and so its interesting that these companies now have taken a pledge that they are not going to, you know, apply to the fda for permission to market unless they have a vaccine that is safe and effective and they are doing that because theres so much hesitation about this vaccine in the u. S. Let take a look at some polling numbers from a cbs poll that was recently done when asked would you take the vaccine. Only 21 would say they would get it as soon as they could and another 58 said they would consider it and wait, and 21, is one out of five said they would never get it. Those numbers arent great. Obviously we want people to take a safe and effective vaccine as quickly as possible to get out of this pandemic, but those numbers just show the hesitation. Yeah. Its really scary how many people already dont trust this, and in terms of building trust, you need to sample the correct proportion of the population, right, and they have had a huge challenge in getting enough minorities, especially black americans, to sign on to these tests, but theres a new ad campaign out today trying to change that is correct right . Thats right. So this is an ad campaign that will be on Major Tv Networks as well as univision, b. E. T. And other networks that are specifically focused on the latino and black communities, and lets take a look at take a look at why they need to have more minorities in these trials. So dr. Fauci has said that he wants to see about 64 of the participants be from minority communities. When you look at modernas numbers its only 26 and pfizer is only 19 . You need minorities, as you said, pope, because you need to see how it works in a diverse population, but also you need minorities because in your trials you need people who are likely to come in contact with the virus or else youll never know if the vaccine works. Youve got to test, it and so minorities, unfortunately, are more than twice as likely to get coronavirus than white people are, so these ads are aimed at encouraging minorities to join the trials. Lets take a listen to a clip from one of them. We know that someone somewhere is full of hope and strength and wants to take action and will take a step forward to hug their grandkids. Walking the walk and rolling up their sleeves. Reporter so, again, were expecting to see these ads today on Major Television networks. Pop be, jim . Elizabeth cohen, its an important message, thanks very much. Thanks. Lets go down to berlin and more on a Biotech Company there, and their announcement that a vaccine could be ready for approval by midoctober. Fred, youve been covering this for a long time. Are we confident that this company, have they gone through all the phase three trials where they have been able to test this across thousands of people to get a sense both of safety and effectiveness . Reporter hi there, jim. They said they are in the middle of the fades three trial right now. They said so far they have 25,000 participants taking part in some of these trials, including in the united states, including argentina and including here in europe and also in asia as well, so they are saying they are getting that data in. Its interesting, one of the things that elizabeth said is something that this company is very well aware of as well. They told me right now their aim is to have something ready for approval to have this vaccine ready for approval by the middleofoctober, but they also say, of course, all of this depends how many people who are taking part in the studies or in the trials are actually exposed to the virus, so there is still a little bit of unknown. They say it could get pushed back to the end of october, possibly to the beginning of november, but they also say the things that they are seeing so far make them very, very confident, both in the safety and the efficacy of their vaccine candidate. Heres what the ceo told me. I consider this vaccine as a vaccine that is near perfect, which has a near perfect profile, yeah. We have done preclinical experimentsch they have shown that this vaccine is able to protect animals from infection in really tough challenge experiments, and they have, of course, done much more testing than we have published so far and this provides us a lot of confidence in combination with the understanding of the mode of action in combination with the safety data coming in from the trial. Yes, we believe that we have a safe product, and we believe that it will be able to show efficacy. So as you can see there, a very confident ceo of bion tech, and he went out of his way in the interview to say, look, they didnt cut any corners as far as safety is concerned, and they have the regulators along with them the entire time checking their data to make sure they are adhering very closely to everything, and there, of course, bion tech and pfizer, of course, signed that pledge to do all of this according to the highest standards. They say if everything goes according to plan, guys, that they plan to have 100 million doses ready by the end of this year, and they say by 2021 or in 2021 they could have as many as 1. 3 billion. Guys. They are going to need it. Fret kt pleitgen, fascinating reporting. Another official said despite the president s repeated predictions that there will be a vaccine at the end of next month or before the election theres hardly any chance that one will be red re, widely available to americans by election day so the president is repeating his optimism for this quick timeline. Cnns john harwood joins us from the white house. John, you, of course, have the Coronavirus Task force and folks like dr. Fauci on this broadcast says that science is going to rule here. Who is the president listening to on this . Well, the president i think is listening to his own internal dynamics and understanding of what he need for this election. He needs a moodlifter in this country. Hes trailing joe biden in the polls. A large majority of the American People say things are going in the wrong direction in this country, so its not surprising that the president at his News Conference yesterday was holding had out the possibility of breakthrough news on a vaccine sometime before the election. Take a listen. Were going to have a vaccine very soon, maybe even before a very special date, you know what date im talking about. Reporter now, heres the problem with that if you talk to officials close to operation warp speed. One of them said yesterday i dont know of any scientist involved in this effort who thinks were going to get shots in arms any time before election day. Emergency use authorization, perhaps for health care workers, thats one thing, but broad availability to the american public, i dont know of any Public Health expert who is predicting that on any substantial scale before 2021 after the election, guys. Thank you, john. That matters what those experts say to most. Thanks so much. Joining us now a senior scholar at Johns Hopkins university for health security. Good morning. Thanks for being here, doctor. Thanks for having me. The fact that you have are the biggest names in pharmaceuticaled, right merck, pfizer, glaxosmithkline, is at zenica and others signing this pledge they will not seek fda approval until they are really through phase three, how remarkable is it that they feel like they have to do that for the public . I think its a sign of the time, that weve had this degeneration from Pandemic Response from the very beginning an companies have to be really mindful about getting sucked into the politics of this and not being used as some sort of tool to increase confidence when there isnt a reason to have an increase in confidence so this is something that i think is really important, and i do think these companies have made us vaccines for decades and decades and i think we can trust them to do the right thing despite the pressure that they may be getting from politicians to speed things along or to go along with ideas that are not necessarily scientifically based. Doctor, how will we know though, right . Will the data be published in such a way that the doctors like yourself who are looking at the science, not the politics, can be confident that thats whats driven the decision . When i spoke to dr. Fauci last week he made that point. He said well need to see that data, i assume we will see that data with confidence. Is there going to be, you know, a an ability for a public appraisal of these decisions . I think its going to have to be that way, and were going to get our medical journals publishing these articles. Well see other regulatory agencies in the eu and uk, for example, as well as professional societies like the Infectious Disease society of america, American Academy of pediatrics, all weighing in on this evidence so it will help the general public have more confidence and it wont be Something Like what we saw with hydroxychloroquine or convalescent plasma where theres a question looming over the whole decisionmaking process and well be as transparent as process. We want a vaccine people are willing to take and want the data to support that decision so people know the risks and benefits and we dont want a vaccine that doesnt get into peoples arms will be worthless so we need to make sure that we do this correctly. Youre so right. I mean, that is the key difference between a vaccine and vaccination and for it to be effective you need a broad swath of the population to be vaccinated. How do you how do you do that when that cbs news poll just a few weeks ago showed only 21 of americans polled said they would actually get this vaccine right away. I mean, is it too late to turn the tide on that and to really boost confidence . I already think theres been a lot of damage done to the whole vaccination effort by the politics being injected into it. We also have a Vaccine Hesitancy that will capitalize on any false step so theres already going to be people undermining and only 23 of people got the h1n1 vaccine so this will be very challenging, and we have to speak very frankly and honestly to the American People about what the risks and benefits are and what those risks and benefits, where they lie inside different risk groups, if youre old other, if youre pregnant, all of that has to be very transparent. Its a very daunting challenge, Something Like weve never done before. Being o. Lets talk about the good news here because there is good news. The progress on this has been remarkabling right, and the data das seem to be really good for many, if not all of these mainline these mainline vaccines here. Given that, what is the likely timeline that the three of us, our children, were not you may qualify as a Frontline Worker and you do not in terms of health care worker, that this vaccine will be wildly available to the american public. For wide available, i would say were going to be well into 202 is if that happens if everything goes perfect in phase three clinical trials. I think i might be able to get a vaccine by the end of the year if everything went well and we had an emergency use authorization for health care workers, but this is something well take some time to get into the arms of americans and well fighting this virus without a vaccine for several month at a minimum so we need to continue working on testing, tracing it and ice late because the vaccine isnt going to be a magic bullet that we have all of a sudden and everything disappears. Its going to take some time. Yeah. Do you believe, doctor, that when there is a vaccine that is effective and approved by the fda, schools and universities should mandate that every child and every College Student get the vaccine because thats a whole other level of, you know, of debate in the. I do think that this is going to be something that becomes a routine vaccination, and we know that schools mandate the measles vaccine, for example, as part of entry. We know that colleges mandate, for example, the meningitis vaccine as a can be entry soy do think if we have the data of supporting this vaccine is safe and effective and being able to blunt the damage this virus can cause, its something that schools and universities should mandate and i would be supportive of it if the data support it had. Listen this, country had difficulty mandating masks, right, a very simple step so the question is even if there is a push, would it happen practically . Doctor, great to have you on. We appreciate your help on all these questions. Thank you. Well, President Trump is attacking u. S. Military leaders, their motivations, suggesting that they start wars simply to fund defense contractors. Were going to discuss the fallout coming up. Plus, back to school during a pandemic. Some of the biggest districts in the u. S. Are reopening today but with most children still learning online at home. What do parents need to know, and Colgate Universitys president leading by example when it comes to mitigating the spread of covid19. He has spent the last 17 days quarantined in a dorm room right beside students adhering to his own mandatory quarantine. He got out of quarantine at 8 00 a. M. , and hell be here with us this hour. We made usaa insurance for veterans like liz and mike. An army family who is always at the ready. So when they got a little surprise. Two . They didnt panic. They got a bigger car for their soontobebigger family. After shopping around for insurance, they called usaa who helped find the right coverage for them and even some muchneeded savings. That was the easy part. Usaa insurance is made the way liz and mike need it easy. Its ubrelvy. For anytime, anywhere migraine strikes without worrying if its too late, or where i am. One dose can quickly stop migraine in its tracks within two hours. Unlike older medicines, ubrelvy is a pill that directly blocks cgrp protein, believed to be a cause of migraine. Do not take with strong cyp3a4 inhibitors. Most common side effects were nausea and tiredness. Ask about ubrelvy. The anytime, anywhere migraine medicine. Ask about ubrelvy. That includes temperature scan, and sanitizing everythingfe. And all of our staff wearing gloves and masks. Not that mask. This mask. Thats the visionworks difference. Visionworks. See the difference. All right. Its a big day, right . So many kids starting their first day of the new school year. Yeah. But for most of the 1. 8 million u. S. Students doing that, it is online so its very different than what were used to. Complicating things, arance comeware attack is interrupting are first day for a lot of students. No more walks out the front door with the backpacks. Turned around and go back to the bedroom. Cnns Diane Gallagher is following this all. Something like this happened in florida. Now in connecticut. I mean, how many students is this disrupting now . Reporter were looking at the entire Hartford Public School district, they are dealing with this ransomware attack. This is affecting the tracking of the bus system there. They are working hard to get everything back online in hartford, but we saw this last month with students in Miamidade County schools, an attack there that interrupted their learning, and with so many kids going virtual, more than 7 million across the country are online only. 67 of the more than 100 Largest School districts in the country are online at least to start the school year and, you know, with all of them starting today, 14 of the 16 largest districts are starting strictly online. A lot of these districts have just made the decision that it is safer when it comes to the spread of covid19, but there are all sorts of complications that do come with it just from going off line, of course, and dealing with issues that the state of North Carolina dealt with last month. The portal went down on the first day of school. Simple stuff like that to more complex issues to parents having to continue to try to work and also attempt to help and educate their children at home. For sure. Its a huge challenge, diane. Thanks a lot for the reporting from there. Lets go to miami. Beaches were open for holiday weekend. Well have to see that that has led to another spike in covid cases just like we saw after memorial day and at fourth of july. Cnns rosa flores joins us now with more. Florida is on track to mark 12,000 coronavirus deaths, but we have seen some more positive trend lines. Tell us what the big picture is there and then also the concerns about fallout from the holiday. Reporter well, you know, jim, and weave talked about this before. Florida is very curious about how it reports its numbers. If you actually add the number of florida nonresidents and florida residents who have died from the coronavirus, the state of florida has already crossed the grim milestone of more than 12,000 cases, according to the Florida Department of health, 11,871 florida residents have died and 152 nonross dents, but if you look at the big picture, florida is trending in the right direction with the Florida Department of Health Reporting yesterday 1,838 cases. The state has not reported that low of a case count since june 15th. Officials believe some of the mitigation measures that they have implemented are, working, is things like a mask mandate, the curfews, but they also fear that during holidays lake labor day that people will put their gu